The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients - Contacts and Locations

Home

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

This study is ongoing, but not recruiting participants.

Study NCT00002396. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002396

Locations


United States, California
	San Francisco Gen Hosp
	San Francisco, California, United States, 94115

United States, Maryland
	Johns Hopkins Hosp
	Baltimore, Maryland, United States, 21205

United States, Washington
	Univ of Washington / AIDS Clinical Trial Unit
	Seattle, Washington, United States, 98104

Sponsors and Collaborators

Gilead Sciences